Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
We provide a chemotherapy treatment service that offers you both choice and flexibility. Chemotherapy is the use of cytotoxic (anti-cancer) drugs to destroy cancer cells in the body by disrupting the cancer cells and preventing them from growing and dividing.
Dr Hans van der Voet is a senior consultant clinical oncologist and radiotherapy lead at the James Cook University Hospital in Middlesbrough. He qualified at the University of Amsterdam Medical School in 1989 and started his radiotherapy training at The Netherlands Cancer Institute/Anthony van Leeuwenhoek Hospital in Amsterdam in 1990. He took a year out from training to do a clinical fellowship in bladder cancer at the Christie Hospital in Manchester from 1993. After completion of specialist training at the NCI/AvL in 1995, he returned to the Christie hospital as a senior registrar. In 1997 he took up a position as consultant clinical oncologist in Middlesbrough.
Dr Hans van der Voet specialises and manages a busy practice in urological cancers, lower gastrointestinal cancer including anal cancer and sarcoma. He was instrumental in establishing image guided radiotherapy and subsequently intensity modulated radiotherapy in Middlesbrough. He has a fast experience in the treatment of prostate cancer including stereotactic radiotherapy.
Dr Hans van der Voet also has an interest in providing radiotherapy for the treatment of early Dupuytren’s disease and has been treating patients for this condition since 2013. Dr van der Voet is a member of the Northern Cancer Alliance Radiotherapy Expert Advisory Group.
European Society of Radiotherapy and Oncology
The Royal College of Radiologists
NCA Radiotherapy Expert Advisory Group
Dr Hans van der Voet does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Hans van der Voet does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Hans van der Voet does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or